Group 1 - CATL's H-shares reached a new high, closing at HKD 418.20 with a 5.87% increase and a market capitalization of HKD 1.91 trillion, following its successful IPO in May 2023, which raised HKD 35.6572 billion, the largest in Hong Kong this year [1] - Sichuan Baili Tianheng Pharmaceutical's prospectus has automatically lapsed due to not being heard within six months, marking the second time the company has submitted its listing application [2] - KEEP expects a significant reduction in losses for the first half of the year, projecting a loss of approximately HKD 36 million, a 78% decrease year-on-year, with adjusted net profit of about HKD 10 million, attributed to improved business structure and efficiency [3] Group 2 - Jianxi Technology-B announced the successful commercial implantation of its core product, the Ken-Valve, in several hospitals across key provinces, marking a significant milestone in its commercialization process [4] - The Hang Seng Index rose by 0.68% to 24,994.14 points, while the Hang Seng Tech Index increased by 0.84% to 5,585.50 points, and the National Enterprises Index gained 0.60% to 9,040.20 points [5]